• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于Eudragit-肉桂精油的纳米平台的制剂开发、表征与优化及其对耐药细菌的疗效

Formulation development, characterization, and optimization of Eudragit-cinnamon essential oil-based nanoplatform and its efficacy against resistant bacteria.

作者信息

Nawaz Touseef, Ullah Niamat, Ali Muhammad, Rab Safia Obaidur, Ahmad Irfan, Baloch Rabia, Chaman Sadia, Shah Kifayat Ullah, Amin Adnan

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan.

NPRL, Department of Pharmacognosy, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan.

出版信息

Front Chem. 2025 Aug 8;13:1555449. doi: 10.3389/fchem.2025.1555449. eCollection 2025.

DOI:10.3389/fchem.2025.1555449
PMID:40860123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12372591/
Abstract

INTRODUCTION

Microbial resistance is a growing global concern, necessitating the development of novel drug delivery system to combat the resistant bacterial strains. We aimed to formulate Eudragit based cinnamon essential oil loaded nanoplatform against resistant microbial strain.

METHODS

Nanoparticles were characterized for zeta potential, PDI, particle size, SEM, FTIR, entrapment efficiency and drug release kinetic. Box Behnken design with the quadratic model was used to check the effect of independent factors and dependent factors.

RESULTS AND DISCUSSION

The and aureus have shown same MIC value of 1.25 μL/ml while and shown 0.078 and 0.625 μL/ml respectively. Quadratic polynomial equation depicted that stirring speed exhibited negative effect on the PDI, particle size and encapsulation efficiency. The polymer concentration produced positive effect on the particle size, PDI and encapsulation efficiency of the nanoparticles. The predicted response values were as particle size (Y1) 228.9 nm, PDI (Y2) 0.3 and %EE (Y3) 72.75% which were very close to the actual values of response as particle size (Y1) was 230.4 ± 3.46 nm, PDI (Y2) was 0.293 ± 0.022, and %EE (Y3) was 74.9 ± 2.32%. It was concluded that our prepared formulation can be effectively used treat resistant bacterial infections.

摘要

引言

微生物耐药性是一个日益引起全球关注的问题,因此需要开发新型药物递送系统来对抗耐药菌株。我们旨在制备基于Eudragit的负载肉桂精油的纳米平台以对抗耐药微生物菌株。

方法

对纳米颗粒进行zeta电位、PDI、粒径、扫描电子显微镜(SEM)、傅里叶变换红外光谱(FTIR)、包封率和药物释放动力学表征。采用具有二次模型的Box Behnken设计来检验独立因素和相关因素的影响。

结果与讨论

金黄色葡萄球菌和表皮葡萄球菌的最低抑菌浓度(MIC)值均为1.25μL/ml,而大肠杆菌和铜绿假单胞菌的MIC值分别为0.078和0.625μL/ml。二次多项式方程表明搅拌速度对PDI、粒径和包封率有负面影响。聚合物浓度对纳米颗粒的粒径、PDI和包封率有正面影响。预测的响应值为粒径(Y1)228.9nm、PDI(Y2)0.3和包封率(%EE,Y3)72.75%,这与响应的实际值非常接近,实际值为粒径(Y1)230.4±3.46nm、PDI(Y2)0.293±0.022和包封率(%EE,Y3)74.9±2.32%。得出的结论是,我们制备的制剂可有效用于治疗耐药细菌感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/0c10dd9eb23f/fchem-13-1555449-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/21a7ef62afc4/fchem-13-1555449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d523f2db71a8/fchem-13-1555449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4a8c0e874b6f/fchem-13-1555449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/94eabc258266/fchem-13-1555449-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/99cd0ecd041a/fchem-13-1555449-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d9b3f12ceb6b/fchem-13-1555449-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/78591b23a875/fchem-13-1555449-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4e26231071d2/fchem-13-1555449-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/24c649130e73/fchem-13-1555449-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d774766233e9/fchem-13-1555449-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4596966a54cf/fchem-13-1555449-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d24c6054ddc8/fchem-13-1555449-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d92a48460911/fchem-13-1555449-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/0c10dd9eb23f/fchem-13-1555449-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/21a7ef62afc4/fchem-13-1555449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d523f2db71a8/fchem-13-1555449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4a8c0e874b6f/fchem-13-1555449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/94eabc258266/fchem-13-1555449-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/99cd0ecd041a/fchem-13-1555449-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d9b3f12ceb6b/fchem-13-1555449-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/78591b23a875/fchem-13-1555449-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4e26231071d2/fchem-13-1555449-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/24c649130e73/fchem-13-1555449-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d774766233e9/fchem-13-1555449-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/4596966a54cf/fchem-13-1555449-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d24c6054ddc8/fchem-13-1555449-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/d92a48460911/fchem-13-1555449-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dd/12372591/0c10dd9eb23f/fchem-13-1555449-g014.jpg

相似文献

1
Formulation development, characterization, and optimization of Eudragit-cinnamon essential oil-based nanoplatform and its efficacy against resistant bacteria.基于Eudragit-肉桂精油的纳米平台的制剂开发、表征与优化及其对耐药细菌的疗效
Front Chem. 2025 Aug 8;13:1555449. doi: 10.3389/fchem.2025.1555449. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections.载万古霉素的脂质体药物传递系统对耐甲氧西林金黄色葡萄球菌(MRSA)感染的抗菌和抗生物膜潜力。
BMC Biotechnol. 2024 Jul 8;24(1):47. doi: 10.1186/s12896-024-00874-1.
4
Treating Burn Infections With Topical Delivery of Positively Charged Norfloxacin-Loaded Lipid-Polymer Hybrid Nanoparticles.用带正电荷的载诺氟沙星脂质-聚合物杂化纳米颗粒局部给药治疗烧伤感染
Recent Adv Drug Deliv Formul. 2025;19(2):142-155. doi: 10.2174/0126673878316672241122041157.
5
Biological activities of optimized biosynthesized selenium nanoparticles using Proteus mirabilis PQ350419 alone or combined with chitosan and ampicillin against common multidrug-resistant bacteria.单独使用奇异变形杆菌PQ350419或与壳聚糖和氨苄青霉素联合使用优化生物合成的硒纳米颗粒对常见多重耐药菌的生物活性。
Microb Cell Fact. 2025 Jul 5;24(1):159. doi: 10.1186/s12934-025-02783-0.
6
Formulation, Characterization and Cytotoxic Effect of Indomethacin-loaded Nanoparticles.吲哚美辛负载纳米颗粒的制剂、表征及细胞毒性作用
Antiinflamm Antiallergy Agents Med Chem. 2025;24(2):139-148. doi: 10.2174/0118715230348349241126053733.
7
Development and Characterization of LL37 Antimicrobial-Peptide-Loaded Chitosan Nanoparticles: An Antimicrobial Sustained Release System.负载LL37抗菌肽的壳聚糖纳米颗粒的研制与表征:一种抗菌缓释系统。
Polymers (Basel). 2025 Jul 7;17(13):1884. doi: 10.3390/polym17131884.
8
Implementation of the Box-Behnken Design in the Development and Optimization of Methotrexate-Loaded Microsponges for Colon Cancer.Box-Behnken设计在结肠癌用甲氨蝶呤微海绵制剂的研发与优化中的应用
Assay Drug Dev Technol. 2025 Jul;23(5):251-268. doi: 10.1089/adt.2024.073. Epub 2025 Jan 23.
9
Design Optimization and Evaluation of Solid Lipid Nanoparticles of Azelnidipine for the Treatment of Hypertension.用于治疗高血压的阿折地平固体脂质纳米粒的设计优化与评价
Recent Pat Nanotechnol. 2024;18(1):22-32. doi: 10.2174/1872210517666221019102543.
10
Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis.基于半乳糖化修饰给药系统 Eudragit/Gal-PLGA@和厚朴酚治疗溃疡性结肠炎中靶向炎症病灶的研究。
J Pharm Sci. 2024 Sep;113(9):2744-2755. doi: 10.1016/j.xphs.2024.06.010. Epub 2024 Jun 18.

本文引用的文献

1
Antimicrobial Composites Based on Methacrylic Acid-Methyl Methacrylate Electrospun Fibers Stabilized with Copper(II).基于甲基丙烯酸-甲基丙烯酸甲酯电纺纤维的抗菌复合材料,其通过铜(II)稳定。
Molecules. 2024 Jun 14;29(12):2835. doi: 10.3390/molecules29122835.
2
Natural and Synthetic Polymers for Biomedical and Environmental Applications.用于生物医学和环境应用的天然与合成聚合物。
Polymers (Basel). 2024 Apr 20;16(8):1159. doi: 10.3390/polym16081159.
3
Antibacterial activity of cinnamon essential oil and its main component of cinnamaldehyde and the underlying mechanism.
肉桂精油及其主要成分肉桂醛的抗菌活性及潜在机制。
Front Pharmacol. 2024 Mar 11;15:1378434. doi: 10.3389/fphar.2024.1378434. eCollection 2024.
4
Zeta potential changing self-nanoemulsifying drug delivery systems: A newfangled approach for enhancing oral bioavailability of poorly soluble drugs.Zeta 电位变化自微乳给药系统:提高难溶性药物口服生物利用度的一种新方法。
Int J Pharm. 2024 Apr 25;655:123998. doi: 10.1016/j.ijpharm.2024.123998. Epub 2024 Mar 14.
5
Biomaterials for Drug Delivery and Human Applications.用于药物递送及人体应用的生物材料。
Materials (Basel). 2024 Jan 18;17(2):456. doi: 10.3390/ma17020456.
6
Plant-based essential oil encapsulated in nanoemulsions and their enhanced therapeutic applications: An overview.植物源精油包封于纳米乳及其增强治疗应用:概述。
Biotechnol Bioeng. 2024 Feb;121(2):415-433. doi: 10.1002/bit.28590. Epub 2023 Nov 9.
7
Circumventing the Gastrointestinal Barrier for Oral Delivery of Therapeutic Proteins and Peptides (PPTS): Current Trends and Future Trajectories.绕过胃肠道屏障实现治疗性蛋白质和肽的口服递送(PPTS):当前趋势与未来发展轨迹
Curr Drug Deliv. 2024;21(2):211-235. doi: 10.2174/1567201820666230418091506.
8
Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems.作为药物递送系统的纳米颗粒:纳米颗粒物理化学性质对生物系统反应影响的综述
Polymers (Basel). 2023 Mar 23;15(7):1596. doi: 10.3390/polym15071596.
9
Development and Evaluation of Essential Oil-Based Nanoemulgel Formulation for the Treatment of Oral Bacterial Infections.用于治疗口腔细菌感染的精油基纳米乳凝胶制剂的研发与评价
Gels. 2023 Mar 21;9(3):252. doi: 10.3390/gels9030252.
10
Thymol-Loaded Eudragit RS30D Cationic Nanoparticles-Based Hydrogels for Topical Application in Wounds: In Vitro and In Vivo Evaluation.负载百里酚的基于Eudragit RS30D阳离子纳米颗粒的水凝胶在伤口局部应用中的体外和体内评价
Pharmaceutics. 2022 Dec 21;15(1):19. doi: 10.3390/pharmaceutics15010019.